Anthony J. Bolton
Direktor/Vorstandsmitglied bei FIL Ltd.
Ursprung des Netzwerks ersten Grades von Anthony J. Bolton
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
FIL Investment Advisors (UK) Ltd.
 FIL Investment Advisors (UK) Ltd. Investment ManagersFinance FIL Investment Advisors (UK) Ltd. (FIA UK) is a Great Britain-based fund management firm headquartered in Tadworth, Surrey. Founded in 1984, the firm is a wholly-owned subsidiary of FIL Holdings (UK) Limited, which in turn is a wholly-owned subsidiary of FIL Ltd. in Bermuda. FIA UK provides a range of global investment products and services to institutional accounts, mutual funds and other pooled investment vehicles.
123
| Subsidiary | Investment Managers | 123 |
FIL Ltd.
 FIL Ltd. Investment ManagersFinance FIL Ltd. provides investment advisory and financial management services. It offers class investment solutions and retirement expertise to institutions, individuals and advisers. The firm serves retail clients and intermediaries such as banks, financial advisers, and insurance companies. The company was founded by Edward C. Johnson III in 1969 and is headquartered in Pembroke, Bermuda..
16
| Private Company | Investment Managers | 16 |
FIL Investment Management (Hong Kong) Ltd.
 FIL Investment Management (Hong Kong) Ltd. Investment ManagersFinance FIL Investment Management (Hong Kong) Ltd. (FIL-HK) is the wholly-owned, Hong Kong-based investment management subsidiary of FIL Ltd., a privately-owned group headquartered in Bermuda. The firm was founded in 1981 and formerly known as Fidelity Investments Management (Hong Kong) Ltd. FIL-HK offers several mutual funds to investors through over 100 distributors in Hong Kong, which includes retail banks and insurance companies.
14
| Subsidiary | Investment Managers | 14 |
Immodulon Therapeutics Ltd.
 Immodulon Therapeutics Ltd. BiotechnologyHealth Technology Part of Lifexx SA, Immodulon Therapeutics Ltd. is a late-stage clinical biotechnology company based in Uxbridge, UK. Immodulon is developing a highly differentiated cancer immunotherapy approach that primes the patient’s own innate immune system with the aim to significantly enhance the efficacy of a broad range of anti-cancer therapies, including chemotherapy and checkpoint inhibitors. The British company is developing imm-101, a heat-killed mycobacterium obuense, as a broad-spectrum immunomodulatory agent with the potential to treat a range of difficult-to-treat tumors including those considered to be immunologically “ cold, ” such as pancreatic cancer. Immodulon's imm-101 based immunotherapy complements other cancer therapies, including immune checkpoint inhibitors and chemotherapy. The company is focused on developing safe and effective immunotherapy treatments. The company was founded in 2007 by Charles Akle, John L. Stanford. Gertjan Bartlema has been the CEO of the company since 2022.
9
| Subsidiary | Biotechnology | 9 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Anthony J. Bolton
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
FIL Investments International
 FIL Investments International Investment ManagersFinance FIL Investments International (FILII) is an asset management firm headquartered in Tadworth, UK. The firm was founded in 1979 and is a subsidiary of FIL Holdings (UK) Ltd., which is ultimately held by FIL Ltd. in Bermuda. FILII provides investment advisory and management services to their clients. | Investment Managers | Portfolio Manager-Fixed Income Portfolio Manager-Equities Portfolio Manager-Equities Portfolio Manager-Equities Portfolio Manager-Equities Portfolio Manager-Equities Portfolio Manager-Equities Portfolio Manager-Fixed Income Portfolio Manager-Equities Portfolio Manager-Equities Portfolio Manager-Equities Portfolio Manager-Equities Portfolio Manager-Equities Portfolio Manager-Equities Portfolio Manager-Equities Portfolio Manager-Equities Portfolio Manager-Equities Portfolio Manager-Equities Portfolio Manager-Equities Portfolio Manager-Fixed Income Portfolio Manager-Equities Portfolio Manager-Equities Portfolio Manager-Equities Portfolio Manager-Equities | |
Fidelity Management & Research Co. LLC
 Fidelity Management & Research Co. LLC Investment ManagersFinance Fidelity Management & Research Co. (FMR) is a SEC-registered investment advisor headquartered in Boston, Massachusetts. The firm was founded in 1946 and is a subsidiary of FMR LLC, also known as Fidelity Investments. FMR provides investment supervisory services, which include sub-advisory services, to Fidelity's family of mutual funds and exchange-traded funds, qualified tuition programs, privately offered unregistered investment funds, separately managed account clients, and various other institutional accounts. | Investment Managers | Chief Executive Officer Portfolio Manager-Equities Director of Research - Equity Portfolio Manager-Equities Portfolio Manager-Equities Analyst-Equity | |
| INSEAD | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
Colt Technology Services Group Ltd.
 Colt Technology Services Group Ltd. Specialty TelecommunicationsCommunications Colt Technology Services Group Ltd. provides networking, professional and information technology services. It offers optical network services, business internet and VPN, ethernet, voice, cloud and data center, cybersecurity, and wireless backhaul services. The company was founded in 1992 and is headquartered in London, the United Kingdom. | Specialty Telecommunications | Director/Board Member Director/Board Member Chairman | |
Artemis Investment Management LLP
 Artemis Investment Management LLP Investment ManagersFinance Artemis Investment Management LLP (AIM) is a Great Britain-based investment management firm headquartered in London with an additional office in Edinburgh. The firm was founded in 1997 and is a subsidiary of Artemis Strategic Asset Management Ltd., itself a subsidiary of Affiliated Managers Group, Inc. (NYSE: AMG) in the US. AIM manages a range of funds, investment trusts, hedge fund products, venture capital trusts, and pooled and segregated institutional portfolios for both retail and institutional investors. | Investment Managers | Portfolio Manager-Equities Portfolio Manager-Equities | |
Goldman Sachs International
 Goldman Sachs International Investment Banks/BrokersFinance Goldman Sachs International (GSI) is the Great Britain-based, wholly-owned brokerage subsidiary of Goldman Sachs Group UK Ltd., ultimately held by The Goldman Sachs Group, Inc. (NYSE: GS) in the US. The firm was founded in 1988 and formerly known as Trushelfco Ltd. Headquartered in London, GSI provides prime brokerage, securities lending, futures services and financing services for a range of clients such as corporations, financial institutions, governments and high-net worth individuals. | Investment Banks/Brokers | President Market Strategist | |
| Brown University | College/University | Undergraduate Degree Graduate Degree | |
Colt Group Holdings Ltd.
 Colt Group Holdings Ltd. Data Processing ServicesTechnology Services Part of Colt Lux Group Holding SARL, Colt Group Holdings Ltd. is a British company that provides bandwidth and data center services. The company is based in London, UK and was founded in 2018. | Data Processing Services | Director/Board Member Director/Board Member | |
| Princeton University | College/University | Undergraduate Degree Graduate Degree | |
| Harvard Medical School | College/University | Corporate Officer/Principal | |
Beyond Air Ltd.
 Beyond Air Ltd. BiotechnologyHealth Technology Beyond Air, Ltd. is a clinical-stage medical device and biopharmaceutical company engaging in the development of nitric oxide generator and delivery system that uses nitric oxide generated from ambient air and delivers precise amounts of nitric oxide to the lungs for the potential treatment of respiratory and other diseases. The company was founded by Yossef Av-Gay, Amir Avniel, and David Greenberg in May 2011 and is headquartered in Rehovot, Israel. | Biotechnology | Director/Board Member | |
Trek Therapeutics PBC
 Trek Therapeutics PBC Pharmaceuticals: MajorHealth Technology Trek Therapeutics PBC is a for-profit company based in Cambridge, MA. The private company's mission is to develop medicines to treat infectious diseases and make them available to populations in need. The founders of the company, Jerome B. Zeldis and Ann D. Kwong, have collectively participated in developing seven approved antiviral drugs. The company aims to profitably develop safe, novel medicines for infectious diseases at affordable prices. Ann D. Kwong has been the CEO since incorporation. | Pharmaceuticals: Major | Founder | |
| Mali Health Organizing Project | Director/Board Member | ||
| Robert Wood Johnson Medical School | College/University | Corporate Officer/Principal | |
| University of California, Davis | College/University | Corporate Officer/Principal | |
Central New Jersey Council Boy Scouts of America
 Central New Jersey Council Boy Scouts of America Miscellaneous Commercial ServicesCommercial Services Central New Jersey Council Boy Scouts of America provides programs, events and opportunities of a lifetime that serve to shape the lives of young men and women in Central and Northern New Jersey. The company was founded in 1995 and is headquartered in Monmouth Junction, NJ. | Miscellaneous Commercial Services | Director/Board Member | |
| PTC Corp. | Director/Board Member | ||
The Arthritis Foundation
 The Arthritis Foundation Miscellaneous Commercial ServicesCommercial Services Arthritis Foundation provides funds research, advocacy and support services for various kinds of arthritis and related diseases. It offers programs and services including aquatic programs, information about treatment breakthroughs, exercise tips for people with the disease and pain management information. Arthritis Foundation is located in Atlanta, GA. | Miscellaneous Commercial Services | Director/Board Member | |
| International Castlemans Disease Organization | Director/Board Member | ||
| PTC THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
ImmuneRegen BioSciences, Inc.
 ImmuneRegen BioSciences, Inc. Miscellaneous Commercial ServicesCommercial Services ImmuneRegen BioSciences, Inc. researches and develops immunomodulation to improve pulmonary function and stimulating the human immune system. The company is headquartered in Scottsdale, AZ. | Miscellaneous Commercial Services | Director/Board Member | |
Etubics Corp.
 Etubics Corp. BiotechnologyHealth Technology Etubics Corp. develops commercial prophylactic vaccines and immunotherapy products. It offers proprietary immunization platform technology called the etubics platform that develops therapeutic vaccines for colon and breast cancers and preventative vaccines for H1N1 Influenza and HIV. The company was founded by Frank R. Jones in 2003 and is headquartered in Seattle, WA. | Biotechnology | Director/Board Member | |
National Financial Services LLC (Trading Arm)
 National Financial Services LLC (Trading Arm) Investment Banks/BrokersFinance National Financial Services is an operating division and the institutional trading arm of National Financial Services LLC. The firm is a broker/dealer headquartered in Boston. They execute equity and fixed-income securities trades on behalf of institutional clients as well as several Fidelity businesses. Their ultimate parent is FRM LLC. National Financial Services maintains a team of principal traders in New York that make markets in several hundred NASDAQ securities. The firm also has specialists on the Boston Stock Exchange. Their fixed-income operation is a principal dealer in a wide range of taxable and tax-exempt securities. They also underwrite municipal and government agency debt | Investment Banks/Brokers | Director of Research - Equity | |
| METASTAT, INC. | Electrical Products | Chairman | |
| NEXGEL, INC. | Chemicals: Specialty | Director/Board Member | |
| Lehigh University | College/University | Undergraduate Degree | |
The Chartered Institute For Securities & Investment
 The Chartered Institute For Securities & Investment General GovernmentGovernment The Chartered Institute For Securities & Investment operates as securities and investment educational institute. It is the professional body for those who work in the securities and investment industry in the UK and in a growing number of major financial centres round the world. The company was founded in 1992 and is headquartered in London, the United Kingdom. | General Government | Director/Board Member | |
Israel Biotech Fund
 Israel Biotech Fund Investment ManagersFinance Israel Biotech Fund (Israel Biotech) is a venture capital firm founded in 2015 by Yuval Cabilly, David Sidransky, and Gidon Zairi. The firm is headquartered in Rehovot, Israel. | Investment Managers | Consultant / Advisor | |
| NEXIMMUNE, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Biond Biologics Ltd.
 Biond Biologics Ltd. Pharmaceuticals: MajorHealth Technology Biond Biologics Ltd. engages in drug discovery and development. It offers cell-internalizing antibody platform that will enable antibody-targeting of intra-cellular immune factors. The company was founded by Ori Shilo and Tehila Ben-Moshe and is headquartered in Tel Aviv, Israel. The company was founded by Ori Shilo and Tehila Ben-Moshe and is headquartered in Tel Aviv, Israel. | Pharmaceuticals: Major | Director/Board Member | |
| Arthritis Foundation New Jersey Chapter | Director/Board Member | ||
Viralclear Pharmaceuticals, Inc.
 Viralclear Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ViralClear Pharmaceuticals, Inc. manufactures anti-viral drug. The company is headquartered in Westport, CT. | Pharmaceuticals: Major | Chairman | |
| BIOSIG TECHNOLOGIES, INC. | Medical Specialties | Director/Board Member | |
| SORRENTO THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Celularity, Inc. (United States)
 Celularity, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Celularity, Inc. engages in biotechnology company. The firm focuses on the study of placenta. The company was founded in Robert Joseph Hariri Gordon and Peter H. Diamandis in 2016 and is headquartered in Florham Park, NJ. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
| Celgene Global Health | Chief Executive Officer | ||
| BEYOND AIR, INC. | Medical Specialties | Director/Board Member | |
| CLARITAS PHARMACEUTICALS, INC. | Pharmaceuticals: Other | Director/Board Member | |
| Semorex, Inc. | Director/Board Member | ||
| Weill Cornell Medical College | College/University | Corporate Officer/Principal | |
Integer Asset Management (I.A.M) Ltd.
 Integer Asset Management (I.A.M) Ltd. Investment ManagersFinance Integer Asset Management (I.A.M) Ltd. (IAM) is an independent investment advisor headquartered in Ramat Hasharon, Israel. The firm was founded by Tal Eloya in 2012. IAM provides advisory services only to accredited investors. | Investment Managers | Founder | |
| CELGENE | Biotechnology | Chief Tech/Sci/R&D Officer | |
Swiss Re Europe SA
 Swiss Re Europe SA Multi-Line InsuranceFinance Part of Swiss Re AG, Swiss Re Europe SA is a Luxembourger company that provides life, health, and property insurance and reinsurance services. The company is based in Luxembourg, Luxembourg. | Multi-Line Insurance | Chairman | |
Quintes Holding BV
 Quintes Holding BV Financial ConglomeratesFinance Quintes Holding BV operates as financial holding company with activities in the insurance sector. Its brands include Kroezen, Plusdiensten, Commandeur, Wiersma & Walvius, Buro@Work, Finagri, Story, De Mul, Guijt, and Van der Oord. The company was founded in 2012 and is headquartered in Culemborg, Netherlands. | Financial Conglomerates | Director/Board Member | |
Swiss Re International SE
 Swiss Re International SE Multi-Line InsuranceFinance Swiss Re International SE provides non-life insurance service. The company was founded in 2008 and is headquartered in Luxembourg. | Multi-Line Insurance | Chairman |
Statistik
International
| Vereinigte Staaten | 35 |
| Vereinigtes Königreich | 7 |
| Israel | 5 |
| Luxemburg | 4 |
| Frankreich | 2 |
Sektoral
| Health Technology | 16 |
| Finance | 11 |
| Consumer Services | 9 |
| Commercial Services | 5 |
| Communications | 3 |
Operativ
| Director/Board Member | 147 |
| Portfolio Manager-Equities | 107 |
| Chairman | 57 |
| Analyst-Equity | 50 |
| Corporate Officer/Principal | 45 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Jacques de Vaucleroy | 48 |
| Jerome Zeldis | 38 |
| Simon Robertson | 27 |
| Gunn Wærsted | 25 |
| Simon Fraser | 21 |
| Glen Moreno | 20 |
| Abigail Johnson | 17 |
| Richard Davies | 15 |
| Richard Wastcoat | 11 |
| Brett J. Rome | 11 |
| Katherine Collins | 10 |
| Cheryl-Ann Lister | 9 |
| Selwyn Ho | 8 |
| John Moldin | 7 |
| Eric J. Rovick | 7 |
- Börse
- Insiders
- Anthony J. Bolton
- Unternehmensverbindungen
